LIBLICENSE-L Archives

LibLicense-L Discussion Forum

LIBLICENSE-L@LISTSERV.CRL.EDU

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
LIBLICENSE <[log in to unmask]>
Reply To:
LibLicense-L Discussion Forum <[log in to unmask]>
Date:
Tue, 16 Oct 2012 15:00:12 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (47 lines)
From: FrederickFriend <[log in to unmask]>
Date: Tue, 16 Oct 2012 11:14:40 +0100

Why is it that whenever ACS attempt to make a generous gesture it
comes across as mean-hearted, especially by comparison with an
equivalent action by the American Physical Society? No time-limit is
set by APS on access to the papers of the Physics Nobel Prizewinners,
but ACS say "free for a limited time". Perhaps a trivial matter but -
as Stevan Harnad pointed out on the GOAL list - APS has an excellent
record on research-friendly OA policies, and as a member of their
Library Committee in the 1980s, I found APS very open about their
journal budgets and their small surpluses.

The moral is that APS have not suffered any loss as a result of their
long-standing open attitude in both the subscription and OA worlds,
and indeed have enhanced their reputation. So why cannot more society
journal publishers in the US and Europe follow the example of APS in
its research-friendly decisions and not come across as commercial
enterprises defending their profit margins? It is a question of
organisational culture.

Fred Friend
Honorary Director Scholarly Communication UCL
http://www.friendofopenaccess.org.uk

-----Original Message-----
From: Brett R. Thomas <[log in to unmask]>
Date: Mon, Oct 15, 2012 at 7:01 AM

ACS Congratulates the 2012 Nobel Prize in Chemistry Winners

ACS Publications congratulates long time authors Robert J. Lefkowitz
and Brian K. Kobilka on winning the 2012 Nobel Prize in Chemistry for
their studies of G-protein-coupled receptors (GPCRs).  These receptors
allow cells in the body to sense and respond to outside signals and
are the target for several commonly prescribed prescription drugs
including beta blockers, antihistamines and antidepressants.

ACS Publications also congratulates Accounts of Chemical Research
author David Wineland on the 2012 Nobel Prize in Physics and Crystal
Growth & Design author Shinya Yamanaka on the 2012 Nobel Prize
in Physiology or Medicine.

View their research from ACS journals free for a limited time.

<http://c.acs.org/cyatb/511866/0/208052/20363/0/D/0/0/xivv.html>

ATOM RSS1 RSS2